Springer Health+ IME: Podcast to Practice
Episodes
Barriers, Breakthroughs, and the Way Forward | S10E6
18 Feb 2026
Contributed by Lukas
International experts Andreea Nissenkorn, Antonio Gil-Nagel Rein and Takamichi Yamamoto discuss regional barriers to comprehensive, long-term care for...
Evidence-Based Strategies for Treating LGS | S10E5
18 Feb 2026
Contributed by Lukas
International experts Andreea Nissenkorn, Antonio Gil-Nagel Rein and Takamichi Yamamoto explore regional treatment differences for Lennox-Gastaut synd...
LGS Diagnosis and Treatment Across Regions | S10E4
18 Feb 2026
Contributed by Lukas
International experts Andreea Nissenkorn, Antonio Gil-Nagel Rein and Takamichi Yamamoto examine regional differences in Lennox-Gastaut syndrome diagno...
Tools for Timely and Accurate LGS Identification | S10E3
18 Feb 2026
Contributed by Lukas
International experts Andreea Nissenkorn, Antonio Gil-Nagel Rein and Takamichi Yamamoto examine the burden of disease, offering a holistic view of the...
Understanding the Full Burden of LGS | S10E2
18 Feb 2026
Contributed by Lukas
International experts Andreea Nissenkorn, Antonio Gil-Nagel Rein and Takamichi Yamamoto examine the burden of disease, offering a holistic view of the...
Recognizing Lennox-Gastaut Syndrome | S10E1
18 Feb 2026
Contributed by Lukas
International experts Andreea Nissenkorn, Antonio Gil-Nagel Rein and Takamichi Yamamoto elucidate the neurophysiological and genetic factors underpinn...
The patient voice | S9E4
10 Feb 2026
Contributed by Lukas
"Led by Prof. Martin Aringer and Dr. Wiebke Troll A one-to-one conversation between an expert and a patient advocate, focusing on lived experience, t...
Overcoming implementation challenges | S9E3
10 Feb 2026
Contributed by Lukas
Led by Prof. Martin Aringer, Prof. Marta Mosca and Dr. Johanna Mucke A discussion on regional disparities, barriers to guideline adoption, and practi...
Standardising disease activity measurement | S9E2
10 Feb 2026
Contributed by Lukas
Led by Prof. Martin Aringer and Dr. Johanna Mucke Learn about validated tools like LLDAS and DORIS, and how to integrate them into routine care.
Guideline recommendations and the treat-to-target approach | S9E1
10 Feb 2026
Contributed by Lukas
Led by Prof. Martin Aringer and Prof. Marta Mosca Explore the updated EULAR 2023 guidelines and how to implement treat-to-target strategies in clinic...
Key Ketone Monitoring Updates and Highlights From the ADA 2025 Conference | S8E1
03 Jul 2025
Contributed by Lukas
Dr. David Kerr discusses breakthrough data from ADA 2025 and the clinical implications for diabetic ketoacidosis management and ketone monitoring tech...
Embracing gMG advances together: ensuring multidisciplinary collaboration
30 Jun 2025
Contributed by Lukas
Dr. Kelly Gwathmey and Jude Kings discuss the importance of multidisciplinary teamwork in improving outcomes for patients with gMG.
Advances in gMG: implications for practice
24 Jun 2025
Contributed by Lukas
Dr. Kelly Gwathmey and Dr. Sithara Ramdas discuss the evolving treatment landscape in gMG, including pediatric-specific considerations.
New and emerging therapies in gMG: going upstream, T-cell and B-cell targeted therapies
16 Jun 2025
Contributed by Lukas
Dr. Kelly Gwathmey and Dr. Pushpa Narayanaswami discuss emerging B- and T-cell targeted therapies for gMG, highlighting recent clinical trials, mechan...
New and emerging therapies in gMG: FcRn receptor antagonists and complement inhibition
16 Jun 2025
Contributed by Lukas
Dr. Kelly Gwathmey and Dr. Pushpa Narayanaswami discuss clinical evidence and practical considerations for integrating FcRn antagonists and complement...
Deep dive into targeted therapies: understanding IDH1-mutant AML treatments | S6E3
16 Jun 2025
Contributed by Lukas
Prof. Amer Zeidan and Prof. Courtney D. DiNardo discuss the mechanism of action, efficacy, and safety profiles of novel targeted therapies for IDH1-mu...
Understanding gMG
10 Jun 2025
Contributed by Lukas
Dr. Kelly Gwathmey and Dr. Sithara Ramdas discuss the clinical presentation, diagnostic challenges, and treatment considerations for both adult and ju...
Voices of gMG: enhancing patient-centric care
03 Jun 2025
Contributed by Lukas
Janel Worcester-Brown and Dr. Kelly Gwathmey engage in a compelling patient-physician discussion of the realities of living with gMG and the challenge...
Advancing AML treatment: evidence-based regimens and guidelines for R/R AML management | S6E2
03 Jun 2025
Contributed by Lukas
Prof. Amer Zeidan and Dr. Eunice Wang discuss the latest evidence-based regimens and guideline updates for the clinical application of targeted therap...
Unveiling the mysteries of molecular testing in AML: a guide for oncologists | S6E1
20 May 2025
Contributed by Lukas
Prof. Amer Zeidan and Dr. Sanam Loghavi discuss effective strategies for implementing molecular testing and overcoming barriers in clinical practice f...
Key CGM Updates and Highlights From the 2025 Standards of Care in Diabetes Revision by the ADA | S3E4
17 Mar 2025
Contributed by Lukas
Dr. Jennifer Green shares exciting CGM device highlights from the 2025 Standards of Care in Diabetes revision by the ADA.
Importance of interdisciplinary working with the patient at the center | S5E5
07 Feb 2025
Contributed by Lukas
Watch Professor Tina Vilsbøll and patient, Molly Boll, discuss the importance and benefits of effective patient communication, and challenges of SDM ...
Real-world data on anti-amyloid antibody therapies | S1E9
13 Nov 2024
Contributed by Lukas
Episode 9: Claire Paquet discusses the implications of the real-world and recommendation data presented on anti-amyloid antibody therapies for AD
Opportunities for anti-amyloid antibody treatment | S1E8
13 Nov 2024
Contributed by Lukas
Episode 8: Juan Fortea comments on future opportunities for anti-amyloid antibody treament given the consolidation of clinical trial data in the real ...
Key CGM Updates and Highlights from the EASD 2024 Conference | S3E3
03 Oct 2024
Contributed by Lukas
Dr. Jennifer Green discusses breaking news and clinical implications of data presented at EASD 2024 on CGM technology use in type 2 diabetes.
The effects of time on blood-based biomarkers | S1E7
15 Aug 2024
Contributed by Lukas
Petrice Cogswell summarizes research looking at temporal modelling of blood-based biomarkers and when to use them to predict brain amyloid deposition.
Is it too soon to use blood-based biomarkers for AD in primary care? | S1E6
05 Aug 2024
Contributed by Lukas
Michelle Mielke discusses the current status for blood-based biomarker use in primary care in light of research presented at AAIC24.
Discussing the potential for blood based biomarker use | S1E5
05 Aug 2024
Contributed by Lukas
Rik Ossenkoppele discusses the latest research presented on blood-based biomarkers, including their accuracy for diagnosing Alzheimer’s disease and ...
Advances in therapies that work across multiple disease disciplines | S5E4
18 Jul 2024
Contributed by Lukas
Explore advances in therapies available for CKD in T2D and the clinical evidence and guidelines supporting their use with Professor Nilolaus Marx
Improving integration of guidelines for CKD in T2D in clinical practice | S5E3
18 Jul 2024
Contributed by Lukas
Learn about evidence-based guidelines for management of CKD in T2D and how these can be integrated into clinical practice with Professor David Cherney
Improving recognition, diagnosis and classification of CKD in T2D | S5E2
18 Jul 2024
Contributed by Lukas
Listen to Professor Pinar Topsever discuss the risk factors for CKD in T2D, how to recognise and diagnose CKD in patients with T2D, and the barriers t...
Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1
18 Jul 2024
Contributed by Lukas
Listen to Professor Tina Vilsbøll provide an overview of diabetic kidney disease (DKD) and the diabetes-cardio-kidney spectrum, as she discusses the ...
Key CGM Updates and Highlights from the ADA 2024 Conference | S3E2
04 Jul 2024
Contributed by Lukas
Dr. Eugene Wright, Jr. discusses breaking news and clinical implications of data presented at the ADA 2024 conference on CGM technology.
Optimal approaches for resectable ALK-driven NSCLC | S4E3
25 Jun 2024
Contributed by Lukas
Dr. Solange Peters shares invaluable insights into the management of ALK-positive NSCLC with a special focus on adjuvant therapy.
Navigating NSCLC: Merging molecular insights and targeted therapy | S4E2
25 Jun 2024
Contributed by Lukas
Dr. Lizza Hendriks explores a complex case involving a 40-year-old male with ALK-rearranged non-small cell lung cancer (NSCLC).
Targeted therapy for ALK-positive NSCLC: A practical case study | S4E1
25 Jun 2024
Contributed by Lukas
Dr. Jamie L. Schneider, delves into the practical considerations for targeted therapy in ALK-rearranged non-small cell lung cancer (NSCLC) through an ...
Coping with PBC: Treatment challenges and QoL insights | S2E3
25 Jun 2024
Contributed by Lukas
Kris Kowdley meets with patient Sabrina Reeser as they discuss the patient experience of treatment for PBC, including treatment challenges, variabilit...
Key CGM Updates and Highlights from the ATTD 2024 Conference | S3E1
17 Apr 2024
Contributed by Lukas
Dr. Rozalina McCoy discusses breaking news and clinical implications of data presented at the ATTD 2024 conference on CGM technology.
Walking the path of PBC: Navigating symptoms and QoL | S2E2
09 Apr 2024
Contributed by Lukas
David Jones meets with patient and patient advocate Mo Christie as they discuss the patient experience for PBC, including the burden of the disease an...
The evolving landscape of PBC: New therapies and future directions | S2E1
09 Apr 2024
Contributed by Lukas
Kris Kowdley and David Jones share their insights on the evolving landscape of Primary Biliary Cholangitis (PBC), including new and upcoming therapy o...
Breakfast bites: Highlights from CONy 2024 | S1E4
25 Mar 2024
Contributed by Lukas
Professor Zvezdan Pirtošek comments on a session about whether lecanemab treatment should extend beyond 18 months.
Breakfast bites: Highlights from CONy 2024 | S1E3
25 Mar 2024
Contributed by Lukas
Professor Lea Grinberg explains research on how Alzheimer's Disease is linked to sleep disturbance, and whether interventions for bad sleep can stop t...
Breakfast bites: Highlights from ADPD 2024™ | S1E2
13 Mar 2024
Contributed by Lukas
Professor Oskar Hansson summarises sessions from ADPD 2024™ on anti-amyloid immunotherapies
Breakfast bites: Highlights from ADPD 2024™ | S1E1
12 Mar 2024
Contributed by Lukas
Professor Charlotte Teunissen summarises research presented at ADPD 2024™ about alzheimer's biomarkers, a novel assay for multiphosphorylated tau an...